|
DCTN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.139900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.760300E-03 |
| Normal-vs-Stage2 |
4.518600E-01 |
| Normal-vs-Stage3 |
7.422500E-04 |
| Normal-vs-Stage4 |
9.815200E-04 |
| Stage1-vs-Stage2 |
2.138800E-01 |
| Stage1-vs-Stage3 |
2.106400E-01 |
| Stage1-vs-Stage4 |
1.298180E-01 |
| Stage2-vs-Stage3 |
6.042400E-02 |
| Stage2-vs-Stage4 |
4.359800E-02 |
| Stage3-vs-Stage4 |
7.624200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.435060E-03 |
| Normal-vs-AfricanAmerican |
1.912620E-01 |
| Normal-vs-Asian |
1.218230E-02 |
| Caucasian-vs-AfricanAmerican |
4.533600E-01 |
| Caucasian-vs-Asian |
9.676800E-01 |
| AfricanAmerican-vs-Asian |
4.570200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.514250E-02 |
| Normal-vs-Female |
2.998300E-03 |
| Male-vs-Female |
8.766200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.977530E-02 |
| Normal-vs-Age(41-60Yrs) |
4.935300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.641400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.690790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.939000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.036200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.034200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.790200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.714600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.578000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.165900E-02 |
| Classical-VS-Follicular |
4.698200E-01 |
| Classical-VS-Other |
4.463600E-01 |
| Classical-VS-Normal |
2.294100E-02 |
| Tall-VS-Follicular |
1.339190E-01 |
| Tall-VS-Other |
7.902800E-01 |
| Tall-VS-Normal |
7.555900E-04 |
| Follicular-VS-Other |
6.430400E-01 |
| Follicular-VS-Normal |
2.300100E-02 |
| Other-VS-Normal |
1.278200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.276300E-03 |
| Normal-vs-N1 |
4.446600E-04 |
| N0-vs-N1 |
1.580000E-01 |
|
|
